SCHEMBL1286570

SCHEMBL1286570

CCOC(=O)c1c(C(F)(F)F)nn2c(=O)cc(-c3cc(OC)c(OC)c(OC)c3)[nH]c12

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PLAT P00750 5/20 0.50
ESR1 P03372 1/20 0.40
MAPK1 P28482 1/20 0.40
ALDH1A1 P00352 3/20 0.37
LMNA P02545 2/20 0.37
KDM4E B2RXH2 2/20 0.37
HTT P42858 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
SLC10A2 Q12908 2/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
MAPT P10636 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
TSHR P16473 1/20 0.36
HSD17B10 Q99714 1/20 0.36
NPC1 O15118 1/20 0.35
ATM Q13315 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1614704 0.87 PLAT (0.46) PLATESR1MAPK1ALDH1A1LMNA
SCHEMBL1286573 0.86 PLAT (0.51) PLATALDH1A1LMNAKDM4EHTT
SCHEMBL1278820 0.84 PLAT (0.53) PLATALDH1A1LMNAKDM4EHTT
SCHEMBL1279373 0.81 PLAT (0.59) PLATALDH1A1KDM4EKMT2AMAPT
SCHEMBL1286606 0.80 PLAT (0.52) PLATALDH1A1KDM4ENPSR1HSD17B10
SCHEMBL1286578 0.79 PLAT (0.52) PLATALDH1A1KDM4ENPSR1HSD17B10
SCHEMBL1278684 0.78 PLAT (0.56) PLATALDH1A1KDM4EMAPTNPSR1
SCHEMBL15926309 0.78 PLAT (0.47) PLATMAPK1ALDH1A1MEN1KMT2A
SCHEMBL1279125 0.77 PLAT (0.56) PLATALDH1A1KDM4ENPSR1HSD17B10
SCHEMBL1286584 0.77 PLAT (0.56) PLATALDH1A1KDM4ENPSR1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-8796285-B2 Pyrazolo [1,5-a]-pyrimidones derivatives and pharmaceutical compositions and uses thereof HEBEI MEDICAL UNIVERSITY (CN) 2014-08-05 US disclosed
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof PEKING UNIVERSITY (CN) 2012-04-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120088775-A1 Pyrazolo-[1,5-a]-Pyrimidones Derivatives and Pharmaceutical Compositions and Uses Thereof KCNJ2, KCNQ5, KCNJ11 PLAT 1286/4885ESR1 4004/4885MAPK1 1567/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.